Allergen Extract Market Research
ID: PANHCA-25-005782Type: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M MRCO EASTFORT BELVOIR, VA, 22060-5580, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/e066894096514d7fb8c9da30fd124025/view
Timeline
  1. 1
    Posted Jan 3, 2025, 12:00 AM UTC
  2. 2
    Updated Jan 3, 2025, 12:00 AM UTC
  3. 3
    Due Jan 10, 2025, 8:00 PM UTC
Description

The Department of Defense, specifically the Department of the Army, is seeking information from manufacturers and distributors regarding allergen extracts as part of a sources sought notice. The objective is to gain insights into the market for these extracts, particularly identifying which products respondents manufacture or distribute, and to encourage the submission of any unique FDA licenses or patents related to the desired allergen extracts listed in the accompanying document. This initiative is crucial for supporting research and diagnostic applications in public health, as the detailed listing of biological materials includes various concentrations and formulations relevant for scientific study. Interested parties should reach out to Jessie G. Hart at jessie.g.hart.civ@health.mil or Ricardo Cordero Cruz at ricardo.a.corderocruz.civ@health.mil for further information, with a future solicitation expected to be announced on sam.gov.

Point(s) of Contact
Jessie G. hart
jessie.g.hart.civ@health.mil
Ricardo Cordero Cruz
ricardo.a.corderocruz.civ@health.mil
Files
Title
Posted
Allergen Extract Listing for RFI 1-3-2025.xlsx
Jan 3, 2025, 8:05 PM UTC
The document details a comprehensive list of biological materials, highlighting their concentrations and formulations, primarily for research and diagnostic uses. The items are categorized into groups such as epithelia, feathers, fungi, plants, nuts, and various food products, with specific volumetric concentrations noted, often indicated as "W/V" or "BAU" alongside a glycerinated formulation. The file is structured methodically, making it easy to identify specific types of organisms or food products and their corresponding details, such as “1:20 W/V 50% Glycerinated” for many entries. The primary purpose appears to be informing potential federal and state researchers or grant applicants about the types of biological materials they can work with, relevant concentrations, and availability for study or application in various scientific contexts. This aligns with typical government Requests for Proposals (RFPs) and grants intended for biological research initiatives or public health undertakings. The information serves as an essential resource for laboratory settings and provides foundational data for applicants pursuing related grants or projects, underscoring the relevance of biological diversity in scientific research.
Lifecycle
Title
Type
Allergen Extract Market Research
Currently viewing
Sources Sought
Similar Opportunities
Fexofenadine HCL Follow On MOD P00002
Buyer not available
Special Notice: DEPT OF DEFENSE - DEFENSE LOGISTICS AGENCY is seeking Fexofenadine HCL Follow On MOD P00001. Fexofenadine HCL is a drug used to relieve symptoms of seasonal allergies such as runny nose, sneezing, itchy or watery eyes, and itching of the nose or throat. This procurement is for NDC changes. For more information, please contact Catherine Gilbert at catherine.gilbert@dla.mil or 2157374778.
Fexofenadine HCL Follow On
Buyer not available
Special Notice DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is procuring Fexofenadine HCL Follow On. Fexofenadine HCL is typically used as an antihistamine to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, sneezing, hives, and itching.
Molecules
Buyer not available
The Department of Defense, specifically the Department of the Army, is seeking qualified vendors to provide biotin molecules under a total small business set-aside contract. The procurement aims to acquire analytical laboratory instruments, categorized under the NAICS code 334516, which are essential for various laboratory applications. These biotin molecules will play a crucial role in supporting research and development efforts within military and defense contexts. Interested parties should reach out to Carl Lundell at carl.lundell@westpoint.edu or call 845.938.8298 for further details, while Joy Davis can be contacted at joy.l.davis18.civ@army.mil or 315.772.9900 for additional inquiries.
mold remediation supplies
Buyer not available
The Department of Defense, specifically the Department of the Army, is seeking suppliers for mold remediation supplies through a Combined Synopsis/Solicitation. This procurement is set aside for small businesses under the SBA guidelines, aiming to enhance the Army's capabilities in addressing mold-related issues effectively. Mold remediation supplies are critical for maintaining safe and healthy environments in military facilities, ensuring operational readiness and compliance with health standards. Interested vendors can reach out to Marlow Amparo at marlow.amparo@socom.mil or 850-885-7581, or Joy Davis at joy.l.davis18.civ@army.mil or 315-772-9900 for further details regarding the solicitation process.
Small Laboratory Research Animals
Buyer not available
The Department of Defense, specifically the Army Medical Research Acquisition Activity, is seeking a reliable source of small laboratory research animals, including mice, rats, rabbits, guinea pigs, hamsters, and gerbils, along with related services such as diagnostics and surgical support. The procurement aims to ensure that these animals are Specific Pathogen Free (SPF) and bred by accredited facilities, which is crucial for supporting basic research and compliance with Good Laboratory Practices and FDA studies. This initiative is vital for the US Army Medical Research Institute of Infectious Diseases and other DoD agencies to maintain high standards in laboratory research. Interested vendors can reach out to Kirstin Quinn at kirstin.l.quinn.civ@health.mil or call 301-619-2480 for further details regarding the solicitation process.
A Human Multi-Organ Tissue Equivalent Platform to Model High Consequence Threat Agents
Buyer not available
The Department of Defense, through the Army Medical Research Acquisition Activity, is seeking a contractor to develop a Human Multi-Organ Tissue Equivalent Platform aimed at modeling high consequence threat agents. This initiative focuses on creating a micro-engineered organ/tissue equivalent platform that will facilitate the modeling of pathogenic outcomes from emerging infectious diseases and the testing of medical countermeasures, particularly for respiratory viruses such as SARS-CoV-2, MERS, and pandemic H1N1 influenza. The project is critical for enhancing the military's capability to protect warfighters from both natural and manmade threats, ensuring rapid identification of effective medical responses. Interested contractors must submit their capabilities by 10:00 AM EST on April 14, 2025, and can direct inquiries to Kirstin L. Quinn at Kirstin.L.Quinn.civ@health.mil.
RadEye Products
Buyer not available
The Department of Defense, specifically the Department of the Army, is conducting market research to identify potential sources for the procurement of RadEye brand products manufactured by Thermo Fisher Scientific. The required items include various RadEye kits and components, which must be brand new and come with standard manufacturer warranties, to be delivered within 20 days of order placement. These products are crucial for hazard detection and monitoring, underscoring their importance in defense operations. Interested parties must submit documentation proving their status as authorized resellers, along with relevant product information, by April 11, 2025, at 11:00 a.m. ET, to Blake S. Cromer via email at blake.s.cromer.civ@army.mil.
Sources Sought Notice - OMNIBUS IV Small Business On-Ramp
Buyer not available
The Department of Defense, through the U.S. Army Medical Research Acquisition Activity (USAMRAA), is issuing a Sources Sought Notice (SSN) for the OMNIBUS IV Small Business On-Ramp, aimed at identifying small businesses interested in participating in the Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for military medical research and development services. This initiative seeks to engage small businesses across various socioeconomic categories, including 8(a), HUBZone, Women-Owned, Economically Disadvantaged Women-Owned, and Service-Disabled Veteran-Owned, particularly those not currently holding OMNIBUS awards, to enhance the military's health readiness and resilience through innovative research efforts. Interested vendors are encouraged to submit tailored capability statements detailing their relevant experience and interests, as the cumulative ceiling for these contracts is set at $10 billion, with numerous task orders already issued. For further inquiries, interested parties can contact the OMNIBUS IV Group at dha.ncr.cod-fc.mbx.dha-acq-omnibus-iv@health.mil.
Famotidine
Buyer not available
Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Famotidine, a drug used to treat ulcers and gastroesophageal reflux disease (GERD). The contract will include Famotidine 20 MG tablets in various bottle sizes and Famotidine 40 MG tablets in different bottle sizes. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The contract aims to establish a national supply source to provide the items for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The annual usage estimates will be provided in the solicitation. The solicitation is expected to be posted on the DLA Bid Board System (DIBBS) and SAM.gov. For any questions or comments, interested parties should contact Kristen Baraniewicz. The projected solicitation date is August 2022, but DLA reserves the right to issue the solicitation before or after that date.
Request for Information for Structured Product Labeling (SPL) Document Support for DHA R&D - MRDC - ORA
Buyer not available
The Defense Health Agency (DHA) is seeking information through a Request for Information (RFI) regarding Structured Product Labeling (SPL) document support for its Research & Development Medical Research and Development Command (MRDC). The objective is to assess the feasibility of acquiring commercial solutions that facilitate the submission of SPL documents to the FDA for three licensed New Drug Application (NDA) products requiring labeling changes. This initiative is crucial for ensuring compliance with FDA regulations and maintaining the accuracy of product labeling, which is vital for public health and safety. Interested parties must submit their Capabilities Statements by April 17, 2025, detailing their ability to create, update, and submit SPL documents, along with adherence to technical standards and system validation processes. For further inquiries, respondents can contact Alana M. Sowers at alana.m.sowers.civ@health.mil.